REDWOOD CITY, Calif.–(BUSINESS WIRE)–A.P. Pharma, Inc., a specialty pharmaceutical company, today announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application…

WATERTOWN, Mass.–BUSINESS WIRE–pSivida Corp., a specialty pharmaceutical company that is a leader in the development of sustained release ophthalmic drug treatments, today announced that its licensee Alimera Sciences, Inc. reported the submission…

Drug Pricing: Ruling strikes another blow to multinational pharmaceutical companies

Climate Change: Study estimates that nuclear energy leads to substantially fewer pollution-related deaths and greenhouse gas emissions compared with fossil-fuel sources

Earnings: Sinopec and PetroChina struggle in petrochemicals

Structure: Small, hard-to-crystallize molecules can be held in nanoscale scaffolds and analyzed via X-ray

Regulation: Latest research adds fuel to a lawsuit calling for EPA to ban neonicotinoid insecticides

Audience: Risk Manager, Pharmacy ISSUE: Hospira, Inc. notified healthcare professional of a voluntary nationwide user-level recall of one lot of 0.9% Sodium Chloride Injection, USP, 1000 mL, Flexible Container, NDC 0409-7983-09. This action is due…

A compromised proposal to prevent plant accidents is the topic of next chemical safety board hearing

Patent Suits: Court weighs legality of settlements that may delay market entry of generic medicines